Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

BACKGROUND: Correlations between development of hand–foot syndrome (HFS) and efficacy in patients receiving capecitabine (CAP)-containing therapy are reported in the literature. We explored the relationship between HFS and efficacy in patients receiving CAP plus bevacizumab (BEV) in the TURANDOT ran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Zielinski, Christoph, Lang, Istvan, Beslija, Semir, Kahan, Zsuzsanna, Inbar, Moshe J, Stemmer, Salomon M, Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4815806/
https://ncbi.nlm.nih.gov/pubmed/26657657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados